OR WAIT 15 SECS
© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 25, 2021 07:15pm
Here’s a preview of the featured content to watch for this week on Drug Topics®.
January 25, 2021 07:10pm
January 25, 2021 02:50pm
January 22, 2021 08:19pm
January 22, 2021 06:42pm
January 25, 2021
Results of a study presented in a poster presentation during ASHP Midyear collected data of the available OTC CBD products being sold in Colorado pharmacies.
A recent study examined how insulin levels and body mass index may have ties to mental health concerns.
January 22, 2021
Officials with the FDA have approved cabotegravir and rilpivirine, injectable formulation (Cabenuva; ViiV Healthcare) as a complete regimen for the treatment of HIV-1 infection in adults.
Here's the roundup of the latest coronavirus-related news.
Investigators compared outcomes among patients with COVID-19 and hypertension through modifying blood pressure medication use.
Patients reported more frequent and severe migraines, along with overuse of analgesics.
Alliance will provide insight, education, and training opportunities to pharmaceutical and life sciences professionals.
January 21, 2021
A survey from APhA reported that the majority of pharmacists plan to or have received a COVID-19 vaccine.
A study observed gaps in migraine knowledge in women’s health care providers. Pharmacists can play a role in provider education on prophylaxis and treatment.